Thyrocare Technologies Limited (NSE:THYROCARE)
562.85
+7.35 (1.32%)
Jul 21, 2026, 3:30 PM IST
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 89.43 billion as of July 21, 2026. Its market cap has increased by 42.59% in one year.
Market Cap
89.43B
Enterprise Value
88.05B
Revenue
8.29B
Ranking
n/a
PE Ratio
54.85
Stock Price
562.85
ChartMarket Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 89.43B, an increase of 169.37%. That is a compound annual growth rate of 10.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 89.43B | 25.99% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.64T |
| Divi's Laboratories | 1.92T |
| Apollo Hospitals Enterprise | 1.27T |
| Cipla | 1.15T |
| Strides Pharma Science | 99.08B |
| HealthCare Global Enterprises | 97.92B |
| Sudeep Pharma | 97.45B |
| MedPlus Health Services | 96.24B |